Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:52 PM
Ignite Modification Date:
2025-12-24 @ 10:52 PM
NCT ID:
NCT06219369
Eligibility Criteria:
Inclusion Criteria:
* A minimum of 70 patients who will undergo VATS surgery,
* American Society of Anesthesiologists (ASA) physical classification 1-2-3,
* Aged between 18-65,
* Who have read and accepted the voluntary informed consent form,
* Body mass index (BMI) of \<35.
Exclusion Criteria:
* Patients who refuse to participate in the study,
* BMI \>35,
* ASA physical classifications 4-5,
* Patients unable to perform pain scoring using the NRS system,
* Those allergic to the administered local anesthetic and designated analgesic medication, individuals declaring pregnancy or lactation,
* Patients under 18 or over 65 years of age,
* Uncontrollable anxiety,
* Alcohol and drug addiction,
* Neuromuscular and peripheral nerve diseases,
* Using high doses of opioid medication three days before surgery,
* Widespread chronic pain,
* Diabetes mellitus,
* Hepatic and renal insufficiency,
* Coagulation disorders,
* Using anticoagulant drugs,
* Infection at the site of peripheral block needle insertion,
* History of abdominal surgery or trauma,
* Unable to communicate in Turkish,
* Patients experiencing technical problems while using patient-controlled analgesia,
* Patients for whom the surgical procedure needs to be terminated for any reason before completion, as well as those for whom postoperative extubation is not planned, will not be accepted into the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT06219369
Study Brief:
Protocol Section:
NCT06219369